EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Practical advice in the development of a lyophilized protein drug product

Yuan Cheng iD, Huu Thuy Trang Duong, Qingyan Hu, Mohammed Shameem, Xiaolin Charlie Tang

Antibody Therapeutics · 19.01.2025 · 8 (1) · 13-25

DOI: 10.1093/abt/tbae030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibody Therapeutics, online erschienen am 21.11.2024. Verfasst von Yuan Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Formulation Development Group, Regeneron Pharmaceuticals Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regeneron Pharmaceuticals Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of lyophilized protein drug products is a critical and complex task in the pharmaceutical industry, requiring a comprehensive understanding of the myriad of factors affecting product quality, stability, and the efficiency and robustness of the lyophilization process. This review offers practical advice on the critical aspects of lyophilized protein drug product development. Practical considerations across both the early and late stages of development are discussed, underscoring the necessity of a strategic approach from initial development through to commercialization. The review then delves into formulation optimization strategies that are essential for enhancing protein stability and the efficiency of the lyophilization process. This section outlines stable formulation design and highlights the unique considerations required for high protein concentration lyophilized drug products. It further explores the formulation strategies to enhance the lyophilization process’ efficiency. Moreover, the paper examines the critical elements in selecting primary containers and closures for lyophilized drug products, focusing on vials and dual chamber systems. The analysis encompasses the effects of the container/closure’s material, size, geometry, and fill volume on product quality and process efficiency. Lastly, the review provides practical considerations in lyophilization cycle development, including the design and optimization of the freezing, primary drying, and secondary drying stages to achieve a robust, scalable, and efficient lyophilization process. By offering comprehensive insights into these key areas to enhance their understanding and implementation of best practices in the field, this paper serves as a useful resource for researchers, formulators, and process engineers involved in the development of lyophilized protein drug products.

Schlagwörter

Stichwörter der Autor:innen

early and late stage developmentformulation optimizationlyophilization cycle developmentlyophilized protein drug productprimary container and closure selection

Autor:innen und Institutionen

  • Formulation Development Group, Regeneron Pharmaceuticals Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591, USA.

ORCID-Profile: Yuan Cheng

Förderung

  • Regeneron Pharmaceuticals Inc

Zitieren

APA

Cheng, Y., Duong, H. T. T., Hu, Q., Shameem, M., & Tang, X. C. (2025). Practical advice in the development of a lyophilized protein drug product. Antibody Therapeutics, 8(1), 13-25. https://doi.org/10.1093/abt/tbae030

Vancouver

Cheng Y, Duong HTT, Hu Q, Shameem M, Tang XC. Practical advice in the development of a lyophilized protein drug product. Antibody Therapeutics. 2025;8(1):13-25. doi:10.1093/abt/tbae030

BibTeX
@article{Cheng2025,
  author = {Cheng, Yuan and Duong, Huu Thuy Trang and Hu, Qingyan and Shameem, Mohammed and Tang, Xiaolin Charlie},
  title = {Practical advice in the development of a lyophilized protein drug product},
  journal = {Antibody Therapeutics},
  year = {2025},
  volume = {8},
  number = {1},
  pages = {13--25},
  doi = {10.1093/abt/tbae030}
}
Kostenlos starten →